ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EQT Private Equity and Goldman Sachs to acquire Parexel
July 05, 2021Parexel, a global clinical research organisation (CRO), announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (EQT Private Equity) and the private equity business within Goldman Sachs Asset Management ... -
Puyi Biotechnology Completes Series B Financing
June 02, 2021Puyi (Shanghai) Biotechnology Co., Ltd. recently announced the completion of its Series B financing led by Goldman Sachs Asset Management. The proceeds will be used to further augment R&D and business development. -
Goldman Sachs invests in Aragen Life Sciences
May 20, 2021Aragen Life Sciences, formerly known as GVK Biosciences announced that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders. -
Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs
November 09, 2020Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion.
Pharma Sources Insight January 2025
